Mounjaro for Type 1s, Time-Restricted Eating Results, Finerenone for Kidney Disease in Type 1 & A "Huge" Ozempic Story | TCOYD® Newsy News #6
In this video, you will learn about the following:
✔ Eli Lilly’s new “Surpass T1D” study investigating the use of Mounjaro (tirzepatide) for weight loss and blood sugar control in Type 1 diabetes
✔ Impressive data on Time-Restricted Eating showing how a 4-hour feeding window improved pancreatic function and insulin resistance in early Type 2 diabetes
✔ Results from the “Fine-One” Phase 3 trial demonstrating that Finerenone can prevent the progression of chronic kidney disease in adults with Type 1 diabetes
✔ A factual (and humorous) report on how significant weight loss from GLP-1s like Ozempic can visually increase penile length
✔ An impromptu “Joke Off” between Drs. Edelman and Pettus to celebrate the lighter side of medical news
CHECK OUT OUR LATEST EPISODES OF DIABETES NEWSY NEWS
Higher GLP-1 Dosing & Weight Loss, Extended CGM Wear & New FDA Approvals, Optimal Blood Glucose Targets
TCOYD® Newsy News #5
FDA Denies T1D SGLT Drug, Dexcom/Oura Ring, Abbott's Ketone Monitor, Medtronic KLUE
TCOYD® Newsy News #5
Newsy News is a video series for healthcare professionals & advanced learners living with diabetes to stay up to date on what’s happening in the diabetes world. Inspired by SNL’s Weekend Update, this new video news segment covers the latest updates and exciting advancements in diabetes care and explains how the research translates to real life.
OUR MISSION
Guided by the belief that every person with diabetes has the right to live a healthy, happy, and productive life, TCOYD® educates & motivates people with diabetes to take a more active role in their condition and provides innovative & integrative continuing education to medical professionals caring for people with diabetes.
OUR VISION
For all people with diabetes and their loved ones to have full access to proper education and therapy to aid in the prevention, early detection and aggressive management of diabetes and its complications.
Leave a Reply